Clinical trial successfully repurposes cancer drug for hereditary bleeding disorder!

Here is a link to the publication of the research:

http://dx.doi.org/10.1056/NEJMoa2312749

“Hereditary hemorrhagic telangiectasia (HHT), the world’s second-most-common inherited bleeding disorder, affects approximately 1-in-5,000 people and can have life-threatening complications, but…